Waters Corporation Research and Development Asset Acquired Other than Through Business Combination, Written-off
Waters Corporation (WAT) reported Research and Development Asset Acquired Other than Through Business Combination, Written-off of $5.00 million for the 12-month period ending 2017-12-31, per its 10-K filed 2020-02-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff · last filed 2020-02-25
- Waters Corporation research and development asset acquired other than through business combination, written-off for the quarter ending 2017-12-31 was $0.00.
- Waters Corporation research and development asset acquired other than through business combination, written-off for the quarter ending 2017-09-30 was $0.00.
- Waters Corporation research and development asset acquired other than through business combination, written-off for the quarter ending 2017-07-01 was $0.00.
- Waters Corporation research and development asset acquired other than through business combination, written-off for the quarter ending 2017-04-01 was $5.00M.
- Waters Corporation research and development asset acquired other than through business combination, written-off for fiscal 2017 was $5.00M.
- Waters Corporation research and development asset acquired other than through business combination, written-off for fiscal 2015 was $3.85M, a 75.06% decline from fiscal 2014.
- Waters Corporation research and development asset acquired other than through business combination, written-off for fiscal 2014 was $15.46M.
| Period end | Research and Development Asset Acquired Other than Through Business Combination, Written-off 3 month | Research and Development Asset Acquired Other than Through Business Combination, Written-off 6 month | Research and Development Asset Acquired Other than Through Business Combination, Written-off 9 month | Research and Development Asset Acquired Other than Through Business Combination, Written-off 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $0.00 derived: sum of 2 quarters · filed 2020-02-25 | $0.00 derived: sum of 3 quarters · filed 2020-02-25 | $5.00M 10-K · filed 2020-02-25 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $0.00 derived: sum of 2 quarters · filed 2018-11-02 | $5.00M 10-Q · filed 2018-11-02 | |
| 2017-07-01 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $5.00M 10-Q · filed 2018-08-03 | ||
| 2017-04-01 | $5.00M 10-Q · filed 2018-05-04 | |||
| 2017-03-31 | $5.00M 10-K/A · filed 2019-03-01 | |||
| 2015-12-31 | $3.85M 10-K · filed 2017-02-24 | $3.85M 10-K · filed 2018-02-27 | ||
| 2014-12-31 | $15.46M 10-K · filed 2016-02-26 | $15.46M 10-K · filed 2017-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ILLUMINA, INC. (ILMN) | United States | $41.357B | 32.37 |
| AGILENT TECHNOLOGIES, INC. (A) | United States | $48.720B | 27.14 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |